Search for: "Novartis Pharmaceuticals Inc"
Results 201 - 220
of 394
Sort by Relevance
|
Sort by Date
7 Jul 2011, 2:31 pm
Novartis Pharmaceuticals Corp., ___ F. [read post]
6 Jul 2011, 2:21 am
Biopet Vet Lab, Inc., et. al. [read post]
5 Jul 2011, 1:44 pm
The patents were owned jointly by MedImmune and MRC, who alleged that they had been infringed by Novartis’ sales of ranibizumab, a pharmaceutical product sold under the trade mark Lucentis and is approved for the treatment of an eye condition known as wet age-related macular degeneration. [read post]
30 Jun 2011, 5:00 am
Husqvarna, Inc., 390 N.W.2d 363, 366 (Minn. [read post]
29 Jun 2011, 3:34 am
Sagent Pharmaceuticals, Inc. et al. [read post]
22 Jun 2011, 4:09 am
A-G’s opinion published – Merck & Co Inc. v Deutsches Patent- und Markenamt (EPLAW) (The SPC Blog) US: Supreme Court to revisit patentable subject matter eligibility of medical diagnostic methods: Mayo v Prometheus (Patently-O) (Patent Baristas) (PharmaPatents) (IPBiz) (Patent Law Practice Center) US: Intellectual property problems for personalized medicine (BIOtechNow) US: Supreme Court ruling in Stanford v Roche (IPKat) (IPKat) US: Manager’s Amendment (and… [read post]
15 Jun 2011, 4:56 am
Par Pharmaceutical, Inc. [read post]
12 Jun 2011, 9:17 pm
.; Par Pharmaceutical Inc. [read post]
2 Jun 2011, 12:46 pm
Novartis Pharmaceuticals Corp., 2011 WL 1533467, at *9 (E.D.N.Y. [read post]
26 May 2011, 10:54 am
Novartis Pharmaceuticals Corp., 2010 WL 1463035, at *1 (D.N.J. [read post]
19 May 2011, 1:15 pm
Novartis Pharmaceuticals Corp., ___ F. [read post]
15 May 2011, 8:55 pm
• Defendant: Teva Pharmaceuticals USA Inc. [read post]
11 May 2011, 4:54 am
Allergan, Inc. [read post]
19 Apr 2011, 10:01 am
Novartis Pharmaceuticals, Inc., 06 Civ. 0260 (BMC) (RER), slip op. [read post]
6 Apr 2011, 12:18 am
Chiron Healthcare & Novartis (EPLAW) India firm on ‘NO’ to data exclusivity (SiNApSE) (Generic Pharmaceuticals and IP) (Spicy IP) (Spicy IP) US: CAFC hears oral arguments on patentability of DNA claims: American Molecular Pathology, et. al, v. [read post]
1 Apr 2011, 8:54 pm
Later, he helped the National Biodiversity Institute of Costa Rica ("INBio") negotiate an agreement with pharmaceutical company Merck & Co., Inc., under which INBio received a $1,000,000 payment and $135,000 in scientific laboratory equipment in exchange for bioprospecting for, and preparing chemical extracts of, promising natural chemicals from Costa Rican rainforest organisms. [read post]
26 Mar 2011, 10:17 am
Similar lawsuits have been filed recently against other major companies: Publicis Group S.A., the U.S. business and French advertising company for Toshiba Corp.; Goldman Sachs Group Inc.; and the U.S. unit of Novartis AG. [read post]
23 Mar 2011, 1:30 pm
The drug is jointly developed by Genentech Inc., a member of the Roche group, under an agreement with Novartis Pharma AG. [read post]
22 Mar 2011, 4:21 pm
General New IP resource for Pharma, Biotech and Chem – Compulsory licences, comparing national requirements (IP Think Tank) WIPO and India partner to protect traditional knowledge from misappropriation (WIPO) UN Rapporteur for the Right to Health asked to intervene in the TPP negotiation (KEI) Patents and doctors, and the USTR TPP text (KEI) Biotech industry losing interest in the therapeutic potential of RNAi (Patent Docs) India: The curious case of the ‘data exclusivity’ volte… [read post]
9 Mar 2011, 3:00 am
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]
